Theralase Technologies Inc. V.TLT

2025 Outlook

[ElBorto]

If they are able to complete clinical study enrollment by the end of 2024 what do you think Q1 2025 could look like for price per share or will it not change due to the enrollment being completed?

[chry200030]

It think we are all waiting for the 2027 Outlook when TLT willbe $100+ a share.

[bmk211]

I am holding 25,000 shares. Probably nothing compared to you all.  But this is my first investment as someone I know who is close to me has bladder cancer.   But seriously $100/share that is a bit extreme right?  Would there need to be a theralase clinic on every stretch corner for that to happen?  What's a hypothetical path of how the stock would ever go that high? I

[Oilminerdeluxe]

Well, if it works on GBM and lung too... Happy days.

[CAinPlap]

I also just found out a good friend has been diagnosed with bladder cancer. Hoping we get approved in time to possibly help him.

[Infinity]

Chry2000   I like your thinking.  TLT with the current management cannot get it done.  What we need is a JV or a total buyout before we get to that level.  It is quite possible...

[bmk211]

Wouldn't a buy out help the parent company stock and reduce the upside potential of theralase bringing home the bacon?   A buyout is better than failure but I dont see how that maximizes the companies potential

[Alamir1111]

https://stockhouse.com/news/press-releases/2024/11/19/immunitybio-completes-anktiva-s-post-approval-enrollment-of-the-100th-patient-in

[bmk211]

So buy ibrx?  What does this mean for theralase?

[Bigkahuna57]

@bmk211, welcome to the board.  The historical patient data for the PH2 NMBC trial (compared to other ACT trials for NMIBC) leads to further speculation as to the effects on other cancers.  The general consensus/speculation regarding a very high SP like $100.00 may become a reality once multiple cancer indications have been proven - the first 3 of which has been named. NMIBC, then NSCLC

[Sosak1]

So what are the side effects?

[ElBorto]

So far it looks like the side effects are less concerning than other non-FDA approved drugs. Slide 22 of their corporate presentation looks promising. [url=https://https://theralase.com/wp-content/uploads/2024/10/Theralase-Corporate-Presentation-10-15-2024-2.pdf][/url]

[ElBorto]

Apparently I don't know how to post links here. Tips are welcomed https://theralase.com/wp-content/uploads/2024/10/Theralase-Corporate-Presentation-10-15-2024-2.pdf

[bmk211]

Thank you BK.  that makes a lot of sense! 

[rollthedice10]

Well, to get into the big leagues which is where TLT is headed for, you need big resourses, distribution chains, larger R&D , etc etc. Building a better mousetrap that you can't get to market would indeed be failure. Structuring the JV will be critical so that both sides win. The only way I would like to see a buyout would be a cash/shares offering to shareholders.. Cash, plus shares in

[charlierock]

Lots of discussion regarding JV, buyouts etc which is fun to speculate about, however none of this happens until we get BTD. Personally I think TLT should be granted BTD and AA based on the fact that the data shows us superior to anything else out there including zero side effects, relative low cost and the dire need for an effective treatment. I really don't like an outside authority ( the

[bmk211]

In a few posts above IBRX (immunity bio)  they had good results too

[rollthedice10]

I agree, nothing will really happen until some positive news on BTD. Securing BTD gives TLT a giant bargaining chip and I too think that it is on the way. There is no way big pharma is not aware of what Theralase has and where it could go. I would not be surprised if some prelimanary talks are already under way. Not to put the cart before the horse, but I feel good. Waiting and anticipating is

[Dumbeldorfwhite]

Talk about over embellishing. No it's not side effect free. In fact 1 person died during the trial which given the investigation was declared unrelated but that doesn't mean the FDA won't want to hear what went wrong. Then the first 12 we're so underdosed how could they even get side effects so there's that so I could realistically see the FDa saying well you have 75 patients

[riverrrow]

You conveniently forgot to mention that the CR for the 12 underdosed patients was actually pretty good.  And if a patient in the trial dies because he was in a car accident does it matter to the FDA?  

[CancerSlayer]

IP currently constitutes the main value of this company, especially if we attain a BTD (bigger bargaining chip).  In order to better protect that IP, I'd rather see this company find a suitable out-licensing partner which would help replenish our coffers & continue to build upon our proof of concept momentum.  A JV can not only be complicated, time-consuming & expensive, it

[BlueFranky]

Damn it Cancer Slayer, you never cease to provide this board with unbiased clarity and dare I say, hope.  Thanks once again for all of your efforts!

[Alamir1111]

11000 volume. .285 c after 15 years of  company existence boy that is a good  stuff.Keep pumping boys

[Infinity]

The outlook for 2025 is not good it is not better it is the BEST.  My gut feeling, we will get BTD in 2024.  We may even AA.  After that, we need a Big Pharma to carry on to get FDA approval.  Getting FDA approval requires many connections, right political climate, Excellent Lobbyists.  TLT simply does not have the resources to follow through.  My best case scenario

[CancerSlayer]

Certainly....if we were to put a lens on just clinical development stage/progress, being a company with a nearly completed Ph II (& no requirements for a Ph III) & assuming we obtain a BTD, such progress should leapfrog us into "approvable" drug territory in the eyes of Big Pharma & hence make us a prime target, especially considering all of the gaps yet to be filled due to:

[CancerSlayer]

Correction... 7)  Achieving efficacy & durability, but at the expense of one or a combination        of the first four (not three) I lost count...

[BlueFranky]

It's totally surreal.  To think that we're sitting next to a soon to be preeminent FDA endosed molecule, potentially capable of treating innumerable types of cancer...with grandkids one day saying:  Can you believe they got in at less than two bits a share? Good luck indeed!

[Beano349]

BTD approval will move the price. I happen to think its low even for a pharma with no cash but that's really it. If we get BTD we can go to like .70, raise cash and start and complete more studies and hope for a buyout!

[menoalittle]

BTD approval will take it a lot higher than 70 cents.

[Beano349]

I hope so, I thought one in 3 are approved with BTD. 

[fecats]

I think about 20% succeed 

[Longholder99]

Rate of approval is higher for innovative oncology treatments than other diseases. 

[fecats]

Honestly I look at all the pre-BTD delays as a positive. They are making sure the odds are vastly improved 

[Longholder99]

Or making a case for Advanced Approval.

[Johnandrose22]

Thinking the same, Longholder 99!